The American Cancer Society has set a challenge goal to reduce overall cancer mortality 40% between 2015 and 2035, a goal set by applying favorable cancer mortality trends among college graduates to the population as a whole. The report is published in the ACS's peer-review journal, CA: A Cancer Journal for Clinicians.
The Community Oncology Alliance is launching a national campaign to highlight the negative impact of pharmacy benefit managers on patients with cancer. The “PBM Abuses” campaign will ensure PBM middlemen abuse of patients with cancer is not lost in policy deliberations in Washington.
Hungary has joined the agency as a new Participating State, according to the International Agency for Research on Cancer.
Primo “Lucky” Lara was named deputy chair of SWOG Cancer Research Network and Kathy Albain now serves as vice chair of SWOG Cancer Research Network. xxx:moreThe
The Tisch Cancer Institute and the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai have launched the Center for Computational Immunology, a hub that will help researchers studying cancer, genomics, machine learning, and immunology collaborate to find targeted immunotherapies.
Memorial Sloan Kettering Cancer Center has formed MSK Kids, which spotlights MSK's pediatric cancer capabilities.
The National Comprehensive Cancer Network and the NCCN Foundation announced four recipients of the annual Young Investigator Awards. These awards provide funding and study support to some of the most promising early-career cancer researchers from across the 28 leading academic cancer centers that comprise NCCN.
Donald Johann Jr. has been awarded a $1.47 million grant from FDA to continue a clinical trial to determine if new approaches can be developed to monitor and screen for lung cancer with a blood test.
The Prostate Cancer Foundation has published a revised version of its Prostate Cancer Patient Guide, which is available for download here.
USC Norris Comprehensive Cancer Center and UCSF Helen Diller Comprehensive Cancer Center joined a program with Lazarex Cancer Foundation program combining financial reimbursement, outreach, and educational programs to help cancer patients learn about and access advanced treatment in clinical trials.
